Navigation Links
MaxCyte to Present at BIO-Europe Spring 2008 Conference
Date:4/7/2008

GAITHERSBURG, Md., April 7, 2008 /PRNewswire/ -- MaxCyte, Inc., a clinical-stage therapeutics company and pioneer in clinical scale, non-viral cell loading systems, announces that Anthony Recupero, Ph.D., Vice President Business Development at MaxCyte, will present on Tuesday, April 8, 2008, at 2:00PM at the BIO-Europe Spring 2008 Conference in Madrid, Spain. Dr. Recupero's presentation will discuss the development of engineered cell based therapies in the context of clinical experiences in cardiopulmonary diseases and novel approaches to cancer immunotherapy as well as drug delivery.

About MaxCyte

MaxCyte is a clinical-stage cell therapeutics company with a rapidly growing pipeline of product development partnerships in cell-based therapies. The Company's proprietary, non-viral, ex vivo cell loading technology provides safety, scalability and reproducibility capabilities which are fundamental to commercializing successful cell-based therapies. MaxCyte has demonstrated the value of its versatile technology in partnered therapeutic programs in oncology, pulmonary, metabolic and infectious diseases as well as in development collaborations with leading researchers. Current clinical programs with MaxCyte-engineered cells include: a Phase IIa clinical study for treatment of chronic lymphocytic leukemia (CLL) and a Phase IIa study using engineered stem cells for the treatment of primary Pulmonary Arterial Hypertension (PAH). MaxCyte has recently partnered with Medinet (JP) to commercialize a cell based therapy to be launched in 2008. In addition, there are advanced preclinical programs in oncology and regenerative medicine. More than 16 commercial and academic partners are currently using the MaxCyte technology. The MaxCyte system has an FDA Master File in place at the Center for Biologics Evaluation and Research (CBER).

For more information, visit http://www.maxcyte.com.


'/>"/>
SOURCE MaxCyte, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Binex and MaxCyte Collaborate on Cancer Immunotherapy Research
2. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
3. Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences
4. Prometic to present at the American Chemical Society
5. Pharmasset to Present at the Canaccord Adams Hepatitis C Conference on Wednesday, April 9th
6. Parks Associates Digital Health Analyst to Present Latest Research and Forecasts at ATA Show
7. Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
8. Anadys Pharmaceuticals to Present at the CanAccord Adams Hepatitis C Conference
9. DiObex Announces Presentation of Scientific Poster at Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
10. NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update
11. Seven Abstracts Featuring Exelixis Compounds Accepted for Presentation at 2008 ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory ... services, today announced that the Company has been informed ... Hong Kong listed company and a ... agreement (the "Agreement") to purchase the Company,s outstanding 7% ...
(Date:5/4/2015)... Marianjoy Rehabilitation Hospital ... and hand impairments by acquiring the Armeo®Spring arm ... network site. , Secured through grant support of ... treatment option for patients with upper extremity weakness ... one of just four Illinois providers offering treatment ...
(Date:5/1/2015)... May 1, 2015 /CNW/ - Softchoice, a leading North American IT ... the proud recipient of two Cisco® Partner Summit Country awards. ... the Year and Security Partner of the Year for ... place this week in Montreal . ... two Cisco partner awards at this year,s conference," said ...
(Date:5/1/2015)... RESEARCH TRIANGLE PARK, N.C. , May 1, 2015 /PRNewswire/ ... Roger Jeffs , Ph.D., President and Co-Chief Executive Officer ... the company,s business at the Deutsche Bank 40 th ... . The presentation will take place on Wednesday, ... be accessed via a live webcast on the United Therapeutics ...
Breaking Biology Technology:China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR 2China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR 3Marianjoy Acquires Armeo®Spring Arm and Hand Rehabilitation Exoskeleton at Oakbrook Terrace Facility 2Softchoice recognized with two Country Awards at Cisco Partner Summit 2015 2
... LOS ANGELES, May 22, 2012 Genesis Biopharma, ... cancer immunotherapies, was mentioned favorably in an article ... can be accessed at the following link: ... Genesis Biopharma, Inc. Genesis ...
... May 22, 2012  Paratek Pharmaceuticals, Inc. today ... Corporate Development, has been appointed President, Chief Executive ... Bigger, following his resignation earlier this year.  In ... at Pfizer and Wyeth and who led regulatory ...
... coating of reflective metal can actually make something less visible, ... an invisible, light-detecting device that can "see without being seen." ... covered by a thin cap of gold. By adjusting the ... refer to as tuning the geometries they capitalize on ...
Cached Biology Technology:Genesis Biopharma Mentioned Favorably in BioMedReports Article 2Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors 2Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors 3Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors 4Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors 5Cloak of invisibility: Engineers use plasmonics to create an invisible photodetector 2Cloak of invisibility: Engineers use plasmonics to create an invisible photodetector 3
(Date:4/1/2015)... Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces the ... wallets is underway to early access pre-order customers. ... usage at retail outlets including Walmart, Target, AT&T, Dunkin, ... Wocket was accepted at all outlets and very easy ...
(Date:3/31/2015)... -- Elephant Talk Communications Corp. (NYSE MKT: ETAK) ("Elephant Talk" ... Network Architecture (ET Software DNA® 2.0) platforms and cyber ... million for the year ended December 31, 2014 as ... ended December 31, 2013. At the ... multi-year transition away from its legacy landline business to ...
(Date:3/30/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) ... Recognition Market in Automotive Sector 2014-2018" report to ... Gesture Recognition market in Automotive Sector to grow at ... Gesture recognition is the ability of a device ... individual. Gesture recognition technology can be 2D-based or 3D-based. ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... found that the number of pests and disease outbreaks in ... The review "The consequences of Tree Pests and ... Southampton, Cambridge, Oxford and St Andrews is published today (15 ... shows that the experience of widespread death of trees, similar ...
... Clinic Lerner Research Institute have discovered recent genetic mutations ... of malaria annuallychanges that may render tens of millions ... infection. Peter A. Zimmerman, professor of international health, ... of Medicine, and David Serre, a scientific staff member ...
... , Nov. 14, 2013 Wake Forest Baptist Medical ... first-of-its-kind strategic affiliation agreement in the Triad with Cornerstone ... Cornerstone Health Enablement Strategic Solutions, LLC (CHESS). ... both partners for new models of health care delivery ...
Cached Biology News:Rising concerns over tree pests and diseases 2Vivax malaria may be evolving around natural defense 2Vivax malaria may be evolving around natural defense 3Wake Forest Baptist Medical Center and Cornerstone Health Care Join in Unique Affiliation 2Wake Forest Baptist Medical Center and Cornerstone Health Care Join in Unique Affiliation 3
... and finishing services are tailored to ... large-scale 5' screening or full length ... experience with large-scale genome projects and ... ideal cDNA outsourcing solution. In addition, ...
... Agencourt offers quick turnaround sequencing of individual ... and high copy plasmids. Agencourt's world-class, high ... Phred20 bases per day. The key ... service are 24 48 hour sample ...
Great for biotinylating DNA/RNA probes...
...
Biology Products: